Structure, dynamics and selectivity in the sulfotransferase family

Drug Metabolism Reviews

Volumn 45, Issue 4, 2013, Pages 423-430

  Leyh, Thomas S ^a   Cook, Ian ^a   Wang, Ting ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Isomerization; Metabolism; Molecular dynamics; Structure; Substrate inhibition; Sulfotransferase; SULT; Synergy

Indexed keywords

NUCLEOTIDE; PRASTERONE; RALOXIFENE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 2A1; UNCLASSIFIED DRUG;

DESORPTION; ENZYME STRUCTURE; ISOMERIZATION; LIGAND BINDING; MOLECULAR DYNAMICS; MUTATION; OSTEOPOROSIS; REVIEW; SIMULATION; WILD TYPE;

ANIMALS; BINDING SITES; CYTOSOL; HUMANS; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; SUBSTRATE SPECIFICITY; SULFOTRANSFERASES;

EID: 84887359121     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2013.835625     Document Type: Review

References (58)

1. Allali-Hassani A, Pan PW, Dombrovski L, et al. (2007). Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol 5:e97.
2. Alnouti Y, Klaassen CD. (2006). Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255. (Pubitemid 44400443)
3. Bai Q, Xu L, Kakiyama G, et al. (2011). Sulfation of 25- hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 214:350-356.
4. Berger I, Guttman C, Amar D, et al. (2011). The molecular basis for the broad substrate specificity of human sulfotransferase 1A1. PLoS One 6:e26794.
5. Chang HJ, Shi R, Rehse P, Lin SX. (2004). Identifying androsterone (ADT) as a cognate substrate for human dehydroepiandrosterone sulfotransferase (DHEA-ST) important for steroid homeostasis: Structure of the enzyme-ADT complex. J Biol Chem 279:2689-2696. (Pubitemid 38114257)
6. Cook I, Wang T, Almo SC, et al. (2013a). The gate that governs sulfotransferase selectivity. Biochemistry 52:415-424.
7. Cook I, Wang T, Almo SC, et al. (2013b). Testing the sulfotransferase molecular pore hypothesis. J Biol Chem 288:8619-8626.
8. Cook I, Wang T, Falany CN, Leyh TS. (2012). A nucleotide-gated molecular pore selects sulfotransferase substrates. Biochemistry 51: 5674-5683.
9. Cook IT, Duniec-Dmuchowski Z, Kocarek TA, et al. (2009). 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: Formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver-receptor activation. Drug Metab Dispos 37:2069-2078.
10. Cook IT, Leyh TS, Kadlubar SA, Falany CN. (2010). Structural rearrangment of SULT2A1: Effects on dehydroepiandrosterone and raloxifene sulfation. Horm Mol Biol Clin Invest 1:81-87.
11. Dong D, Ako R, Wu B. (2012). Crystal structures of human sulfotransferases: Insights into the mechanisms of action and substrate selectivity. Expert Opin Drug Metab Toxicol 8:635-646.
12. Duffel MW, Jakoby WB. (1981). On the mechanism of aryl sulfotransferase. J Biol Chem 256:11123-11127.
13. Falany CN. (1997). Enzymology of human cytosolic sulfotransferases.FASEB J 11:206-216. (Pubitemid 27118321)
14. Falany CN, Vazquez ME, Heroux JA, Roth JA. (1990). Purification and characterization of human liver phenol-sulfating phenol sulfotransferase.Arch Biochem Biophys 278:312-318. (Pubitemid 20126057)
15. Falany CN, Vazquez ME, Kalb JM. (1989). Purification and characterization of human liver dehydroepiandrosterone sulphotransferase.Biochem J 260:641-646. (Pubitemid 19155657)
16. Falany JL, Azziz R, Falany CN. (1998). Identification and characterization of cytosolic sulfotransferases in normal human endometrium.Chem Biol Interact 109:329-339. (Pubitemid 28161124)
17. Falany JL, Falany CN. (1996). Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.Endocrinology 137:1395-1401. (Pubitemid 26095258)
18. Falany JL, Macrina N, Falany CN. (2002). Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Res Treat 74:167-176. (Pubitemid 34816222)
19. Falany JL, Pilloff DE, Leyh TS, Falany CN. (2006). Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.Drug Metab Dispos 34:361-368. (Pubitemid 43290893)
20. Gamage NU, Duggleby RG, Barnett AC, et al. (2003). Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem 278: 7655-7662. (Pubitemid 36800775)
21. Gamage NU, Tsvetanov S, Duggleby RG, et al. (2005). The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates. J Biol Chem 280:41482-41486. (Pubitemid 41832208)
22. Gillespie J. (1981). The Causes of Molecular Evolution. Oxford, UK: Oxford University Press.
23. Goresky CA. (1963). A linear method for determining liver sinusoidal and extravascular volumes. Am J Physiol 204:626-640.
24. Gulcan HO, Duffel MW. (2011). Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: Studies on the formation of catalytically non-productive enzyme complexes. Arch Biochem Biophys 507:232-240.
25. Hallbrucker C, Vom Dahl S, Lang F, et al. (1991). Modification of liver cell volume by insulin and glucagon. Pflugers Arch 418:519-521.
26. Jordan VC. (2007). SERMs: Meeting the promise of multifunctional medicines. J Natl Cancer Inst 99:350-356. (Pubitemid 47078725)
27. Kakuta Y, Pedersen LG, Carter CW, et al. (1997). Crystal structure of estrogen sulphotransferase. Nat Struct Biol 4:904-908. (Pubitemid 27479440)
28. Kase ET, Andersen B, Nebb HI, et al. (2006). 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes. Biochim Biophys Acta 1761:1515-1522. (Pubitemid 44822667)
29. Klaassen CD, Boles JW. (1997). Sulfation and sulfotransferases 5: The importance of 30-phosphoadenosine 50-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J 11:404-418. (Pubitemid 27259982)
30. Kotov A, Falany JL, Wang J, Falany CN. (1999). Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 68:137-144. (Pubitemid 29242843)
31. Labrie F, Bélanger A, Luu-The V, et al. (1998). DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging. Steroids 63:322-328. (Pubitemid 28265670)
32. Latté KP, Appel KE, Lampen A. (2011). Health benefits and possible risks of broccoli-an overview. Food Chem Toxicol 49: 3287-3309.
33. Lu J, Li H, Zhang J, et al. (2010). Crystal structures of SULT1A2 and SULT1A1 *3: Insights into the substrate inhibition and the role of Tyr149 in SULT1A2. Biochem Biophys Res Commun 396: 429-434.
34. Lu LY, Hsieh YC, Liu MY, et al. (2008). Identification and characterization of two amino acids critical for the substrate inhibition of human dehydroepiandrosterone sulfotransferase (SULT2A1). Mol Pharmacol 73:660-668.
35. Mesiano S, Jaffe RB. (1997). Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 18:378-403. (Pubitemid 27246882)
36. Mishell DR, Thorneycroft IH, Nagata Y, et al. (1973). Serum gonadotropin and steroid patterns in early human gestation. Am J Obstet Gynecol 117:631-642.
37. Moore KL. (2003). The biology and enzymology of protein tyrosine O-sulfation. J Biol Chem 278:24243-24246. (Pubitemid 37548571)
38. Morris ME, Levy G. (1983). Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate. Clin Pharmacol Ther 33:529-536. (Pubitemid 13093775)
39. Nowell S, Falany CN. (2006). Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 25:1673-1678.
40. Okanoue T, Ohta M, Ou O, et al. (1985). Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study. Lab Invest 53:534-540. (Pubitemid 16204929)
41. Pedersen LC, Petrotchenko E, Shevtsov S, Negishi M. (2002). Crystal structure of the human estrogen sulfotransferase-PAPS complex: Evidence for catalytic role of Ser137 in the sulfuryl transfer reaction.J Biol Chem 277:17928-17932. (Pubitemid 34967603)
42. Pedersen LC, Petrotchenko EV, Negishi M. (2000). Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase. FEBS Lett 475: 61-64. (Pubitemid 30331079)
43. Petrotchenko EV, Pedersen LC, Borchers CH, et al. (2001). The dimerization motif of cytosolic sulfotransferases. FEBS Lett 490: 39-43. (Pubitemid 32126640)
44. Poeppel P, Habetha M, Marcão A, et al. (2005). Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum. FEBS J 272: 1179-1188. (Pubitemid 40314937)
45. Rehse PH, Zhou M, Lin SX. (2002). Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate.Biochem J 364:165-171. (Pubitemid 34538959)
46. Renwick AB, Ball SE, Tredger JM, et al. (2002). Inhibition of zaleplon metabolism by cimetidine in the human liver: In vitro studies with subcellular fractions and precision-cut liver slices. Xenobiotica 32: 849-862. (Pubitemid 35155520)
47. Riches Z, Stanley EL, Bloomer JC, Coughtrie MW. (2009). Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: The SULT "pie". Drug Metab Dispos 37:2255-2261.
48. Shore LS, Gurevitz M, Shemesh M. (1993). Estrogen as an environmental pollutant. Bull Environ Contam Toxicol 51:361-366. (Pubitemid 23212067)
49. Sun M, Leyh TS. (2010). The human estrogen sulfotransferase: A halfsite reactive enzyme. Biochemistry 49:4779-4785.
50. Teubner W, Meinl W, Florian S, et al. (2007). Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404:207-215. (Pubitemid 46849592)
51. Tyapochkin E, Cook PF, Chen G. (2008). Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase. Biochemistry 47:11894-11899.
52. Tyapochkin E, Cook PF, Chen G. (2009). para-Nitrophenyl sulfate activation of human sulfotransferase 1A1 is consistent with intercepting the E-PAP complex and reformation of E-PAPS. J Biol Chem 284: 29357-29364.
53. Van Koevering MT, Gill DR, Owens FN, et al. (1995). Effect of time on feed on performance of feedlot steers, carcass characteristics, and tenderness and composition of longissimus muscles. J Anim Sci 73: 21-28.
54. Verdonk ML, Berdini V, Hartshorn MJ, et al. (2004). Virtual screening using protein-ligand docking: Avoiding artificial enrichment. J Chem Inf Comput Sci 44:793-806.
55. Waterhouse AL. (2002). Wine phenolics. Ann N Y Acad Sci 957:21-36. (Pubitemid 34721651)
56. Wynne HA, Wood P, Herd B, et al. (1992). The association of age with the activity of alcohol dehydrogenase in human liver. Age Ageing 21: 417-420. (Pubitemid 23048662)
57. Zhang H, Varlamova O, Vargas FM, et al. (1998). Sulfuryl transfer: The catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 273:10888-10892. (Pubitemid 28204925)
58. Zollner G, Trauner M. (2006). Molecular mechanisms of cholestasis.Wien Med Wochenschr 156:380-385. (Pubitemid 44182023)